Hyderabad, May 27 -- : Aurobindo Pharma Limited reported a slight dip in its consolidated net profit for the fourth quarter ended March 31,25, despite a 10.6 per cent up in revenue.
The Hyderabad-based pharma company's net profit during the quarter slightly declined 0.5 per cent to Rs 903 crore from Rs 907 crore in the corresponding period in the previous year, the drug maker said in a release here on Monday evening.
Consolidated revenue from operations during the quarter increased 10.6 percent to Rs 8,382 crore against Rs 7,580 crore in the corresponding quarter in the previous year.
However, for the full fiscal year (FY25), the consolidated net profit rose 9.9 percent to Rs 3,485 crore as against Rs 3,169 crore in the previous year. Th...